小RNA
生物
疾病
冠状病毒
核糖核酸
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
病毒学
病毒
癌变
计算生物学
2019年冠状病毒病(COVID-19)
免疫学
基因
生物信息学
传染病(医学专业)
医学
遗传学
病理
作者
Asim Azhar,Wajihul Hasan Khan,Khaled Alhosaini,Mohammad Amjad Kamal
出处
期刊:Current Drug Metabolism
[Bentham Science]
日期:2022-04-01
卷期号:23 (4): 283-298
被引量:2
标识
DOI:10.2174/1389200223666220321102824
摘要
Coronavirus disease-2019 (COVID-19) is a highly infectious disease caused by newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the inception of SARS-CoV-2 in Wuhan, China, the virus has traveled more than 200 countries globally. The role of SARS-CoV-2 in COVID-19 has been thoroughly investigated and reviewed in the last 22 months or so; however, a comprehensive outline of miRNAs in SARS-CoV- 2 infection is still missing. The genetic material of SARS-CoV-2 is a single-stranded RNA molecule nearly 29 kb in size. RNA is composed of numerous sub-constituents RNA is found in the cells in a number of forms. including microRNAs (miRNAs). miRNAs play an essential role in biological processes like apoptosis, cellular metabolism, cell death, cell movement, oncogenesis, intracellular signaling, immunity, and infection. Lately, miRNAs have been involved in SARS-CoV-2 infection, though the clear demonstration of miRNAs in the SARS-CoV-2 infection is not fully elucidated. The present review article summarizes recent findings of miRNAs associated with SARS-CoV-2 infection. We presented various facets of miRNAs. miRNAs as the protagonists in viral infection, the occurrence of miRNA in cellular receptors, expression of miRNAs in multiple diseases, miRNA as a biomarker, and miRNA as a therapeutic tool have been discussed in detail. We also presented the vaccine status available in various countries.
科研通智能强力驱动
Strongly Powered by AbleSci AI